Cancer discovery news

Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.

Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID
Immunotherapy could work against bowel cancers resistant to important targeted treatment

08/07/19

Patients with bowel cancer who have stopped responding to a widely used targeted drug could benefit from immunotherapy, a major new study reveals.
ICR Logo
ASCO 2019: ICR-discovered drug shows promise in phase I clinical trial

01/06/19

A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage has shown promising results in two clinical trials.
oesophageal cancer 547x410
Gene test predicts likelihood of stomach or oesophageal cancer relapse

27/11/18

A new test could improve care for patients with stomach or oesophageal cancer by predicting their likelihood of relapse after chemotherapy and surgery.
Histological slide showing prostate cancer 4.3 ratio
Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer

27/06/18

A new form of immunotherapy reactivates the response to hormone treatment in advanced prostate cancer, a study in mice and human prostate cancer cells has found.
ICR Logo
Leading UK scientist reveals likely cause of childhood leukaemia

21/05/18

A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia and that the disease may be preventable.
DNA Array news sidebar
Researchers discover 40 genes involved in early development of myeloma

09/04/18

Researchers have revealed 40 genes involved in the development of myeloma, increasing our understanding of the complex genetics behind the incurable blood cancer.
An MRI scanner at the Royal Marsden Hospital
Special device facilitates imaging of mice on clinical MRI scanners for neuroblastoma research

30/10/17

A special device for holding mice while they undergo magnetic resonance imaging (MRI) scans on clinical MRI machines – those used on humans – can enhance imaging investigations in mouse models of neuroblastoma, researchers have found.
Yellow pills in dispensing tray
Scientists uncover a deadly ‘addiction’ in oesophageal cancer

22/08/17

Scientists have discovered a new way of attacking oesophageal cancer cells that could make use of an existing drug in a new approach to treatment.
Radiotherapy machine at The Royal Marsden Hospital
Drug makes head-and-neck cancer more sensitive to radiotherapy

06/04/17

A drug that has shown promise in breast and lung cancer trials also makes the combination of chemotherapy and radiotherapy more successful at killing head-and-neck cancers, a new study has found.
MRI brain scan
Largest-ever brain cancer study reveals new secrets to inherited risk

27/03/17

Scientists have uncovered a treasure trove of information about the genetic causes of brain cancer in the largest-ever study of the disease.
ICR Logo
Hodgkin lymphoma survivors at high risk of second cancers

13/03/17

Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.
Myeloma of sphenoid sinus. Wellcome Images / Creative Commons by-nc-nd 4.0
New research uncovers mechanism for genetic risk of myeloma

24/11/16

Researchers have identified a mechanism that may explain how a key genetic variant acts to increase the risk of developing myeloma.